NFKB1 and osteosarcoma: On the other hand, the p65 subunit has an active role in the ability of osteosarcomas to resist the cytotoxic effects of doxorubicin, highlighting the importance of canonical NF-κB signaling as a critical mechanism underlying the chemoresistance of sarcomas.